scholarly article | Q13442814 |
P50 | author | Jennifer Allen | Q42678278 |
P2093 | author name string | M David | |
J L Veerman | |||
P2860 | cites work | Peri-operative glycaemic control regimens for preventing surgical site infections in adults | Q24240025 |
Nosocomial infections in surgical patients in the United States, January 1986-June 1992. National Nosocomial Infections Surveillance (NNIS) System | Q70579371 | ||
Ceftriaxone vs cefuroxime for infection prophylaxis in coronary bypass surgery | Q72338582 | ||
Cost analysis of antibiotic prophylaxis in clean head and neck surgery | Q72584458 | ||
The rate and cost of hospital-acquired infections occurring in patients admitted to selected specialties of a district general hospital in England and the national burden imposed | Q73613108 | ||
POSTOPERATIVE WOUND INFECTIONS: THE INFLUENCE OF ULTRAVIOLET IRRADIATION OF THE OPERATING ROOM AND OF VARIOUS OTHER FACTORS | Q76877972 | ||
Prospective, randomized, double-blind study of prophylactic antibiotics in axillary lymph node dissection | Q77424596 | ||
Prevalence of 90-days postoperative wound infections after cardiac surgery | Q78693704 | ||
Ertapenem versus cefotetan prophylaxis in elective colorectal surgery | Q79445510 | ||
Hospital costs associated with surgical complications: a report from the private-sector National Surgical Quality Improvement Program | Q80799552 | ||
Surgical site infections | Q83399816 | ||
Hospital costs associated with surgical site infections in general and vascular surgery patients | Q84370285 | ||
Randomized clinical trial of perioperative selective decontamination of the digestive tract versus placebo in elective gastrointestinal surgery | Q84549306 | ||
Clinical practice guidelines for antimicrobial prophylaxis in surgery | Q85911799 | ||
The Measurement of Observer Agreement for Categorical Data | Q26778373 | ||
Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement | Q27860606 | ||
Is antibiotic prophylaxis in surgery a generally effective intervention? Testing a generic hypothesis over a set of meta-analyses. | Q30375663 | ||
Antibiotic prophylaxis in laparoscopic cholecystectomy: a randomized controlled trial | Q34142362 | ||
Strategies to prevent surgical site infections in acute care hospitals: 2014 update | Q34712478 | ||
Identification of randomized controlled trials in systematic reviews: accuracy and reliability of screening records | Q34733075 | ||
The cost-effectiveness of wound-edge protection devices compared to standard care in reducing surgical site infection after laparotomy: an economic evaluation alongside the ROSSINI trial | Q35153067 | ||
Benchmarking for prevention: the Centers for Disease Control and Prevention's National Nosocomial Infections Surveillance (NNIS) system experience. | Q35690098 | ||
Comparison of clinical and economic outcomes of two antibiotic prophylaxis regimens for sternal wound infection in high-risk patients following coronary artery bypass grafting surgery: a prospective randomised double-blind controlled trial | Q35954260 | ||
Surgical site infection - a European perspective of incidence and economic burden | Q36488286 | ||
Beyond 30 days: does limiting the duration of surgical site infection follow-up limit detection? | Q36716575 | ||
Prospective study of Clostridium difficile intestinal colonization and disease following single-dose antibiotic prophylaxis in surgery | Q36752752 | ||
Systematic Review and Cost Analysis Comparing Use of chlorhexidine with Use of Iodine for Preoperative Skin Antisepsis to Prevent Surgical Site Infection | Q37324846 | ||
Surgical site infections: how high are the costs? | Q37501641 | ||
Method agreement analysis: a review of correct methodology | Q37688515 | ||
Systematic review and meta-analysis of preoperative antisepsis with chlorhexidine versus povidone–iodine in clean-contaminated surgery | Q37794105 | ||
Thermoregulation and risk of surgical site infection | Q37874078 | ||
Financial impact of surgical site infections on hospitals: the hospital management perspective | Q38130613 | ||
The economic burden of complications occurring in major surgical procedures: a systematic review | Q38156058 | ||
Economic case for intraoperative interventions to prevent surgical-site infection. | Q39000390 | ||
The effects of preoperative oral antibiotic use on the development of surgical site infection after elective colorectal resections: A retrospective cohort analysis in consecutively operated 90 patients | Q39554549 | ||
CDC definitions for nosocomial infections, 1988 | Q39605670 | ||
Reduction of hospital cost and administration of prophylactic antibiotherapy in gynecological surgery | Q41853983 | ||
Cost-effectiveness of perioperative selective decontamination of the digestive tract versus placebo in elective gastrointestinal surgery. | Q42287625 | ||
Surgical site infection: incidence and impact on hospital utilization and treatment costs | Q43568579 | ||
Antibiotic prophylaxis with cefotaxime in gastroduodenal and biliary surgery | Q43688596 | ||
Prospective, randomized, double-blind trial comparing teicoplanin and cefazolin as antibiotic prophylaxis in prosthetic vascular surgery | Q43717125 | ||
Cefamandole versus cefazolin in vascular surgical wound infection prophylaxis: cost-effectiveness and risk factors | Q45165787 | ||
Costs Associated With Surgical Site Infections in Veterans Affairs Hospitals. | Q45328895 | ||
Comparative costs of ertapenem and cefotetan as prophylaxis for elective colorectal surgery | Q46491068 | ||
The influence of single dose intravenous antibiotics on faecal flora and emergence of Clostridium difficile. | Q54454267 | ||
Clinical and economic burden of surgical site infection (SSI) and predicted financial consequences of elimination of SSI from an English hospital. | Q54547219 | ||
Consolidated Health Economic Evaluation Reporting Standards (CHEERS) statement | Q56880246 | ||
Guideline for prevention of surgical site infection, 1999. Hospital Infection Control Practices Advisory Committee | Q64132021 | ||
CDC definitions of nosocomial surgical site infections, 1992: a modification of CDC definitions of surgical wound infections | Q64135964 | ||
Single-dose cephalosporin prophylaxis of 929 surgical procedures in a prepaid group practice: a prospective, randomized comparison of cefoperazone and cefotaxime | Q69019177 | ||
Antimicrobial prophylaxis for contaminated head and neck surgery | Q70309618 | ||
Cost-benefit analysis of cephradine and mezlocillin prophylaxis for abdominal and vaginal hysterectomy | Q70416045 | ||
P433 | issue | 3 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | systematic review | Q1504425 |
cost-effectiveness analysis | Q1754768 | ||
P304 | page(s) | 81-98 | |
P577 | publication date | 2018-04-14 | |
P1433 | published in | BJS Open | Q73378415 |
P1476 | title | Systematic review of the cost-effectiveness of preoperative antibiotic prophylaxis in reducing surgical-site infection | |
P478 | volume | 2 |
Q90676608 | A comprehensive unit-based safety program for the reduction of surgical site infections in plastic surgery and hand surgery |
Q92502253 | Efficacy of adjunctive azithromycin versus single-dose cephalosporin prophylaxis for caesarean scar defect: study protocol for a randomised controlled trial |
Q91936397 | Highlighting the gaps in quantifying the economic burden of surgical site infections associated with antimicrobial-resistant bacteria |
Q92205375 | Preoperative and operation-related risk factors for postoperative nosocomial infections in pediatric patients: A retrospective cohort study |